discovered that gly‐tRF plays tumor‐promoting role in HCC by targeting NDFIP2 and activating the AKT signaling pathway.[20] However, research on the role of tRFs in HCC is limited. This evidence concerns the gene AKT1 and hepatocellular carcinoma.